Michael Nally

Mike Nally is the Chief Executive Officer of Generate Biomedicines and is a CEO-partner at Flagship Pioneering. Mike brings significant experience leading global organizations across and is passionate about working with teams and partners to bring innovations to patients. 

Mike previously served as Chief Marketing Officer at Merck & Co. In this role, Mike was responsible for Global Marketing and Brand Strategy across a vast portfolio, exceeding $40B in revenue, of innovative medicines and vaccines. 

Prior to this role, Mike served as President of Global Vaccines at Merck, providing a broad portfolio of pediatric, adolescent, and adult vaccines to the world. In this position, Mike and his team worked to drive a dramatic increase in the reach and public health impact of vaccines, while delivering significant business growth.

Additionally, Mike has led the company’s business in Sweden and the UK, focusing on the development and implementation of innovative, customer-centered approaches that delivered improved business results and accelerated patient access to our medicines. He has also held a variety of positions in Commercial Operations, Business Development and Investor Relations.

Mike currently serves on the Board of Directors of PPG Industries and is a member of the PPG Audit and Technology and Environment Committees.

Mike holds an MBA from Harvard Business School, a degree in Accounting and Finance from the London School of Economics and a BA in Economics from Middlebury College.